Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Cambridge based COO’ operating in the Health Care space. If you think a COO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Michael Anstey
Co-Founder and Chief Operating Officer of Proteorex Therapeutics Inc.
Michael Anstey is an Investment Director specialising in healthcare investments. Before joining CIC he was a Principal in the Healthcare Practice Area at The Boston Consulting Group’s (BCG) Toronto office. Michael has experience in advising multinational healthcare businesses across North America, Europe, India, and Japan on a broad range of topics, including corporate strategy, sales and marketing, new launches, R&D and medical strategy, and M&A. Michael was co-founder and COO of an early stage biotechnology company focused on developing small molecule drugs that target protein-protein interactions implicated in disease. Prior to BCG, Michael worked in venture capital, where he focused on investing in early stage healthcare and life science businesses. Michael earned his DPhil in Zoology in the field of neurobiology, jointly supervised by professors at the University of Cambridge and the University of Oxford. Michael sits on the board of Bicycle Therapeutics.
Follow Michael Anstey:
About Cambridge Innovation Capital, Proteorex Therapeutics Inc.: Expanding horizons to find cures
Kathryn Penkus Corzo
Chief Operating Officer of bit.bio
Kathryn Corzo is the Chief Operating Officer of bit.bio. She has more than 25 years of experience in drug development, both early and late, across a variety of indications and platforms.
Follow Kathryn Penkus Corzo:
About bit.bio: Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
Glenn Robertelli
Co-Founder & Chief Operating Officer of Admetsys
Follow Glenn Robertelli:
About Admetsys: For people at diabetic risk, glucose control is at its most crucial while in hospital or surgery.
Martin Hao
Chief Operating Officer of Healthera
Martin is an internationally experienced entrepreneur and engineer who is the lead inventor of Healthera’s core technology.
Follow Martin Hao:
About Healthera: Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.
Sherden Timmins
Co-founder & Chief Operating Officer of Camallergy
Sherden led the formation of Camallergy and spin-out from Cambridge University Hospitals following his MBA at the Cambridge Judge Business School. He designed the Cambridge Peanut Allergy Clinic, and led start-up funding rounds and early drug development in preparation for clinical trials. An engineering graduate from Imperial College London and a former management consultant at top-tier firms Booz & Co. (now Strategy&) and Accenture, Sherden has experience across a range of industries in strategy and managing complex and technical programmes.
Follow Sherden Timmins:
About Camallergy: Camallergy develops and provides new treatments for common food allergies.
David Howton
Chief Operating Officer & General Counsel of AavantiBio
Follow David Howton:
About AavantiBio: AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Andrew Shawcross
COO of Endomag
Dr. Shawcross has 25 years’ experience in industrially based scientific R&D, built initially on his time with ICI, Zeneca, and Avecia, through to more recent experience with Xennia, CDT and now Endomag. Originally trained as a chemist, Andy’s career has taken him into the areas of dyes/pigments, polymers, formulation, semiconductors, nanotechnology, inkjet, displays and medical devices. In the last 15 years, Andy has held a wide range of technical and project management roles, as well as gaining significant experience in sales, business development, quality, regulatory and operational management. Andy holds a Ph.D. in Organic Chemistry from Northumbria University.
Follow Andrew Shawcross:
About Endomag: Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.
Jacob Cohen
Co-founder & COO of Medumo
Follow Jacob Cohen:
About Medumo: Medumo helps healthcare organizations deliver the right instructions to the right patients at the right time using automated SMS and email.
Romain Marmot
Deputy CEO, Chief Operating Officer – US, Oncology Division Coordinator, Co-founder of Voluntis
Romain is Chief Operations Officer of Voluntis and heads the company’s North American operations in Cambridge, MA. He has more than 15 years of experience in digital health and software medical devices. He holds an MSc from École Centrale Paris in applied mathematics.
Follow Romain Marmot:
About Voluntis: Voluntis is a healthcare-related software company specialized in patient relationship management.
Minaam Abbas
Chief Operating Officer of angioClast
Follow Minaam Abbas:
About angioClast: angioClast is a Cambridge biotech startup comitted to transform cancer research.
Jonathan Freeman
COO of Anthos Therapeutics
Jonathan Freeman currently works as the COO for Anthos Therapeutics.
Follow Jonathan Freeman:
About Anthos Therapeutics: Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Lothar Koob
COO of LENSAR, Inc.
In addition to serving as LENSAR COO and Director, Lothar Koob is a General Partner and co-founder of Extera Partners, a business advisory group focused on biopharmaceuticals and medical devices. He has more than 35 years of experience successfully managing global life science businesses and developing and commercializing innovative medical products. With expertise that spans the medical device, imaging, and instrumentation industries, Mr. Koob has served in various executive positions managing research and development, operations, sales, marketing, service, quality, and regulatory functions, and was also involved in acquisitions and international joint ventures in Europe and Asia. Mr. Koob has held various positions in global businesses including President of the worldwide ophthalmic business for Zeiss/Humphrey, General Manager of the worldwide ultrasound and MRI businesses for Siemens Medical, and Executive Vice President of Analogic Corporation. He has also been involved with several start-up and later-stage companies in the U.S., Canada, and Europe, and holds board positions with several companies including Vision-Sciences, Inc., Helix Medical Systems Ltd., and Maui Imaging, Inc.
Follow Lothar Koob:
About Extera Partners, LENSAR, Inc.: LENSAR®, Inc., the leader in next-generation femtosecond cataract laser technology, continues focusing on astigmatism with Streamline® IV.
Jerry Brightbill
Chief Operating Officer of YourBio Health
Jerry Brightbill is the Chief Operating Officer at YourBio Health.
Follow Jerry Brightbill:
About YourBio Health: YourBio Health optimizes the interface of diagnostic medicine and healthcare consumer by simplifying blood sampling and testing.
Heather Wasserman
Chief Operating Officer and Chief Business Officer of Remix Therapeutics
Heather Wasserman is the Chief Operating Officer and Chief Business Officer at Remix Therapeutics.
Follow Heather Wasserman:
About Remix Therapeutics: Remix Therapeutics is a biotechnology company that develops novel small molecule therapies.
Mark Ashworth
Chief Operating Officer of Virti
Mark Ashworth is the Chief Operating Officer of Virti.
Follow Mark Ashworth:
About Grapeshot, Virti: Award-winning interactive immersive education for healthcare and beyond
Philip Ashworth
Chief Operating Officer of PatientSource Ltd.
Follow Philip Ashworth:
About : Cloud based clinician designed electronic patient records
